Volume 64, Issue 3

Search all Cancer Chemotherapy and Pharmacology articles

July 2009

25 articles in this issue

Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G₂/M cell cycle arrest and apoptosis
Go Watanabe
Kevin E. Behrns
Robin D. Kim
Original Article 12 December 2008 Pages: 433 - 443
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner
Ana Catarina Pinto
João Nuno Moreira
Sérgio Simões
Original Article 23 December 2008 Pages: 445 - 454
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
Alexandra Leary
L. Assersohn
J. Oates
Original Article 23 December 2008 Pages: 455 - 462
The x _c ⁻ cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Jun Guan
Maisie Lo
Yu-Zhuo Wang
Original Article 24 December 2008 Pages: 463 - 472
Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis
Mitsuharu Hanada
Akemi Baba
Fumio Nishikaku
Original Article Open access 24 December 2008 Pages: 473 - 483
Tumor specific cytotoxicity of β-glucosylceramide: structure–cytotoxicity relationship and anti-tumor activity in vivo
Hirosuke Oku
Changchun Li
Hisami Watanabe
Original Article 23 December 2008 Pages: 485 - 496
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
Won Kim
Jung-Hwan Yoon
Hyo-Suk Lee
Original Article 20 December 2008 Pages: 497 - 507
Application of prolonged microdialysis sampling in carboplatin-treated cancer patients
Inge R. H. M. Konings
Frederike K. Engels
Walter J. Loos
Original Article Open access 20 December 2008 Pages: 509 - 516
Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
S. T. Russell
P. M. A. Siren
M. J. Tisdale
Original Article 27 December 2008 Pages: 517 - 527
Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models
Jarbas Mota Siqueira
Andressa Córneo Gazola
Rosa Maria Ribeiro-do-Valle
Original Article 30 January 2009 Pages: 529 - 538
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib
Yi-He Ling
Tianhong Li
Missak Haigentz Jr
Original Article 08 January 2009 Pages: 539 - 548
Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens
N. Baize
A. Abakar-Mahamat
F. X. Caroli-Bosc
Original Article 04 January 2009 Pages: 549 - 555
A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors
Kuniaki Shirao
Takayuki Yoshino
Shinichiro Yoshino
Original Article 24 January 2009 Pages: 557 - 564
Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation
Koichi Azuma
Tetsuro Sasada
Hisamichi Aizawa
Original Article 03 January 2009 Pages: 565 - 573
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells
Robert W. Robey
Tomasz Obrzut
Susan E. Bates
Original Article 09 January 2009 Pages: 575 - 583
Pegylated liposomal doxorubicin (CAELYX^®) in patients with advanced ovarian cancer: results of a German multicenter observational study
Jalid Sehouli
O. Camara
on behalf of the North-Eastern German Society of Gynecological Oncology (NOGGO)
Original Article 21 January 2009 Pages: 585 - 591
Role of frequency and mechanical index in ultrasonic-enhanced chemotherapy in rats
Bryant J. Staples
Beverly L. Roeder
William G. Pitt
Original Article 07 January 2009 Pages: 593 - 600
The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
Kazim Uygun
Ahmet Bilici
Sernaz Uzunoglu
Original Article 03 January 2009 Pages: 601 - 605
RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines
Cao Yang
Francis J. Hornicek
Zhenfeng Duan
Original Article 06 January 2009 Pages: 607 - 614
Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity
Ivana Ticha
Petra Kleiblova
Zdenek Kleibl
Short Communication 14 March 2009 Pages: 615 - 618
Prolonged accumulation of high-dose methotrexate in a case with large liver cysts
Manabu Kawakami
Hiroki Omori
Toshihiro Soma
Short Communication 25 March 2009 Pages: 619 - 622
Improved survival in patients with breast rhabdoid tumors with multi-agent adjuvant chemotherapy combined with irradiation
Yoshitaka Furuya
Hironobu Yanagie
Hiroshi Yasuhara
Short Communication 26 March 2009 Pages: 623 - 627
MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines
Jonathan T. Sims
Rina Plattner
Short Communication 26 April 2009 Pages: 629 - 633
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors
Keith M. Skubitz
J. Carlos Manivel
Jerry W. Frolich
Short Communication 29 April 2009 Pages: 635 - 640
Oral administration of the GnRH antagonist acyline, in a GIPET^®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics
John Kenneth Amory
Thomas W. Leonard
William J. Bremner
Short Communication 29 May 2009 Pages: 641 - 645

Volume 64, Issue 3

Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G₂/M cell cycle arrest and apoptosis

Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner

A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy

The x _c ⁻ cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis

Tumor specific cytotoxicity of β-glucosylceramide: structure–cytotoxicity relationship and anti-tumor activity in vivo

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients

Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate

Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models

Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib

Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells

Pegylated liposomal doxorubicin (CAELYX^®) in patients with advanced ovarian cancer: results of a German multicenter observational study

Role of frequency and mechanical index in ultrasonic-enhanced chemotherapy in rats

The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck

RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines

Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity

Prolonged accumulation of high-dose methotrexate in a case with large liver cysts

Improved survival in patients with breast rhabdoid tumors with multi-agent adjuvant chemotherapy combined with irradiation

MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines

Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors

Oral administration of the GnRH antagonist acyline, in a GIPET^®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics

Navigation